Credit Suisse highlights 'underappreciated growth drivers' at Smith & Nephew
9th Jun 2021 08:09
(Sharecast News) - Credit Suisse upgraded shares of artificial hip and knee maker Smith & Nephew on Wednesday to 'outperform' from 'neutral', lifting the price target to 1,805p from 1,560p as it pointed to "underappreciated growth drivers".
Read moreSmith & Nephew reinstates guidance as Q1 revenues rise
29th Apr 2021 07:31
(Sharecast News) - Medical products supplier Smith & Nephew reinstated full year guidance after a rise in first quarter revenues driven by increased surgery volumes, acquisitions and new products.
Read moreBerenberg lowers target price on Smith & Nephew
22nd Feb 2021 11:18
(Sharecast News) - Analysts at Berenberg lowered their target price on medical equipment manufacturer Smith & Nephew from £20.05 to £19.85 on Monday, stating the group had sacrificed today "for a better tomorrow".
Read moreSmith & Nephew says Covid impact to remain in H1 as profits fall
18th Feb 2021 07:04
(Sharecast News) - Medical products business Smith & Nephew warned the Covid-19 pandemic impact was likely to continue into the first half of 2021 with uncertainty on the timing of recovery, as it reported a sharp fall in full-year profit.
Read moreMonday broker round-up
11th Jan 2021 12:47
(Sharecast News) - Weir: Credit Suisse downgrades to neutral with a target price of 2,150p.
Read moreSmith & Nephew revenues to drop as more procedures postponed
11th Jan 2021 07:54
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it expects to report a 7% decline in fourth-quarter underlying revenue and a 12% drop in full-year revenues, as more medical procedures are postponed due to rising numbers of coronavirus infections.
Read moreTuesday broker round-up
1st Dec 2020 13:38
(Sharecast News) - Diageo: Deutsche Bank upgrades to buy with a target price of 3,900p.
Read moreFriday broker round-up
30th Oct 2020 13:40
(Sharecast News) - Royal Dutch Shell: Barclays upgrades to equal weight.
Read moreSmith & Nephew sales improve in Q3, US business returns to growth
29th Oct 2020 07:53
(Sharecast News) - Smith & Nephew reported a "significant improvement" in trading in the third quarter on Thursday as global levels of elective surgeries continued to recover following the initial hit from the Covid-19 pandemic, while its US business returned to growth.
Read moreSmith & Nephew prices $1bn bond offering
8th Oct 2020 08:46
(Sharecast News) - Smith & Nephew has priced an offering of $1bn (£770m) of notes at 2.032%, due 2030, it announced on Thursday.
Read moreSmith & Nephew revenue decline slows as markets pick up
1st Oct 2020 07:24
(Sharecast News) - Medical technology company Smith & Nephew updated the market on its recent trading on Thursday, reporting that it expects a third quarter underlying revenue decline of around 4%.
Read moreSmith & Nephew to buy Integra LifeSciences' extremity orthopaedics business
29th Sep 2020 13:31
(Sharecast News) - Smith & Nephew has agreed to buy the extremity orthopaedics business of Integra LifeSciences for $240m.
Read moreMonday broker round-up
24th Aug 2020 10:57
(Sharecast News) - Dechra Pharmaceuticals: Liberum initiates at sell with a target price of 2,740p.
Read moreSector movers: Travel and Leisure boosted by M&A rumours around InterContinental hotels
23rd Aug 2020 23:45
(Sharecast News) - Mergers and acquisitions news-flow continued to drive sector movements at the sector level, this time in the travel and leisure space.
Read moreSmith & Nephew slashes costs after first-half market slump
29th Jul 2020 08:07
(Sharecast News) - Smith & Nephew reported an 18.7% fall in revenue in its first half on Wednesday, to $2.035bn (£1.57bn), as it swung to an operating loss of $5m, from a profit of $419m a year earlier.
Read more